If you have been diagnosed with P.A.D., you need to learn how to lower your risk of heart attack or stroke. Individuals with P.A.D. have more than double the risk of heart attack or stroke compared to people who don't have P.A.D. Now is the time to explore all your treatment options to help reduce that risk, including medications like PLAVIX.

PLAVIX is the only prescription antiplatelet therapy FDA-approved for patients with established P.A.D. to help reduce the risk of heart attack and stroke. Medical guidelines recommend people with P.A.D. take an antiplatelet medicine. PLAVIX, an antiplatelet medicine available by prescription, is proven to help keep platelets from sticking together and forming clots—the cause of most heart attacks and strokes. Together, you and your doctor can design a plan that's right for you and may include P.A.D. medication, diet and exercise.

PLAVIX is prescribed to lower the risk of future heart attack or stroke in patients with established Peripheral Artery Disease.

Learn more about PLAVIX.

Important Safety Information: People with stomach ulcers or other conditions that cause bleeding should not use PLAVIX. Taking PLAVIX alone or with some other medicines, including aspirin, may increase bleeding risk, so tell your doctor when planning surgery. Certain genetic factors and some medicines, such as Prilosec, may affect how PLAVIX works. Tell your doctor all the medicines you take, including aspirin, especially if you’ve had a stroke. If fever, unexplained weakness or confusion develops, tell your doctor promptly. These may be signs of TTP, a rare but potentially life-threatening condition, reported sometimes less than 2 weeks after starting PLAVIX. Other rare but serious side effects may occur.

Please see full prescribing information for more details.

The health information contained herein is provided for general educational
purposes only. Your health-care professional is the single best source of
information regarding your health. Please consult your health-care professional if
you have any questions about your health or treatment.

The information on this site is intended for residents of the United States.

Last Updated: December 2009

  sanofi aventis Bristol-Myers Squibb
 
US.CLO.09.12.043
264US09WA47418
 
sanofi-aventis U.S. LLC
© 2009 Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership. All Rights Reserved.
Please see our Legal Notice, Privacy Policy and Site Map
 
way ahead